Creative Planning’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310K | Buy |
33,102
+3,795
| +13% | +$35.6K | ﹤0.01% | 2861 |
|
|
2025
Q1 | $208K | Buy |
29,307
+8,144
| +38% | +$57.9K | ﹤0.01% | 3026 |
|
|
2024
Q4 | $247K | Buy |
21,163
+8,618
| +69% | +$100K | ﹤0.01% | 2812 |
|
|
2024
Q3 | $258K | Buy |
12,545
+211
| +2% | +$4.34K | ﹤0.01% | 2649 |
|
|
2024
Q2 | $276K | Sell |
12,334
-5,094
| -29% | -$114K | ﹤0.01% | 2411 |
|
|
2024
Q1 | $479K | Buy |
17,428
+8,456
| +94% | +$233K | ﹤0.01% | 1874 |
|
|
2023
Q4 | $274K | Buy |
8,972
+8,757
| +4,073% | +$267K | ﹤0.01% | 2148 |
|
|
2023
Q3 | $6.8K | Buy |
+215
| New | +$6.8K | ﹤0.01% | 2647 |
|
|
2022
Q2 | – | Sell |
-215
| Closed | -$16K | – | 2343 |
|
|
2022
Q1 | $16K | Buy |
+215
| New | +$16K | ﹤0.01% | 2134 |
|
|
2021
Q4 | – | Sell |
-1,810
| Closed | -$243K | – | 2138 |
|
|
2021
Q3 | $243K | Buy |
+1,810
| New | +$243K | ﹤0.01% | 1726 |
|
|
2020
Q2 | – | Sell |
-63,561
| Closed | -$777K | – | 1875 |
|
|
2020
Q1 | $777K | Sell |
63,561
-20,353
| -24% | -$249K | ﹤0.01% | 737 |
|
|
2019
Q4 | $1.23M | Buy |
83,914
+401
| +0.5% | +$5.88K | ﹤0.01% | 696 |
|
|
2019
Q3 | $1.12M | Sell |
83,513
-610
| -0.7% | -$8.14K | ﹤0.01% | 700 |
|
|
2019
Q2 | $1.38M | Buy |
84,123
+6,100
| +8% | +$99.9K | ﹤0.01% | 623 |
|
|
2019
Q1 | $1.33M | Buy |
78,023
+491
| +0.6% | +$8.39K | ﹤0.01% | 615 |
|
|
2018
Q4 | $1.06M | Sell |
77,532
-359
| -0.5% | -$4.9K | ﹤0.01% | 641 |
|
|
2018
Q3 | $2.23M | Sell |
77,891
-469
| -0.6% | -$13.4K | 0.01% | 453 |
|
|
2018
Q2 | $2.14M | Buy |
78,360
+29,430
| +60% | +$805K | 0.01% | 449 |
|
|
2018
Q1 | $1.03M | Buy |
48,930
+480
| +1% | +$10.1K | ﹤0.01% | 715 |
|
|
2017
Q4 | $931K | Buy |
48,450
+37,035
| +324% | +$712K | ﹤0.01% | 767 |
|
|
2017
Q3 | $284K | Buy |
11,415
+8,415
| +281% | +$209K | ﹤0.01% | 1349 |
|
|
2017
Q2 | $48K | Hold |
3,000
| – | – | ﹤0.01% | 2523 |
|
|
2017
Q1 | $42K | Buy |
+3,000
| New | +$42K | ﹤0.01% | 2586 |
|